CVS Stock Chart & Stats
€94.50
-€0.70(-0.74%)
At close: 4:00 PM EDT
€94.50
-€0.70(-0.74%)
Day’s Range― - ―
52-Week Range€53.35 - €96.90
Previous CloseN/A
Volume308.00
Average Volume (3M)316.00
Market Cap
€115.50B
Enterprise Value€158.57K
Total Cash (Recent Filing)€11.80B
Total Debt (Recent Filing)€78.34B
Price to Earnings (P/E)45.2
Beta0.23
Next Earnings
Aug 05, 2026EPS Estimate
1.6Next Dividend Ex-DateN/A
Dividend Yield2.5%
Share Statistics
EPS (TTM)2.31
Shares Outstanding1,275,927,200
10 Day Avg. Volume284
30 Day Avg. Volume316
Financial Highlights & Ratios
PEG Ratio-0.92
Price to Book (P/B)1.34
Price to Sales (P/S)0.25
P/FCF Ratio12.88
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€96.38Price Target Upside1.99% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering17
EPS Forecast (FY)6.54
Revenue Forecast (FY)€359.09B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationSustained operating cash flow ($10.3B TTM) and healthy free cash flow ($7.4B TTM) provide durable internal funding for debt paydown, reinvestment in care delivery and technology, and dividend support. This cash buffer improves resilience to margin volatility and funds multi-year strategic initiatives.
Vertical Integration And ScaleThe integrated model (insurer, PBM, retail/specialty pharmacy) creates structural advantages: retention through cross-selling, the ability to steer volume to owned channels, and coordinated care programs that can lower system costs. Scale supports procurement leverage and long-term competitive positioning.
Aetna Margin Recovery And Operational WinsMaterial AOI improvement and a sharply improved MBR reflect underwriting and utilization progress at Aetna. A clearer path to target margins by 2028 improves predictability of insurance earnings, reduces downside to enterprise cash flow, and supports durable margin recovery across multi-year planning horizons.
Bears Say
Compressed Profitability And ReturnsA sharp decline in net margin and ROE (to ~3.9% TTM) reduces the company's earnings power relative to its asset and equity base. Lower profitability constrains reinvestment potential, weakens return on capital, and leaves less cushion against future cost shocks or regulatory-driven revenue pressure.
PBM Rebate And Margin HeadwindsContractual rebate guarantees and client-driven price improvements compress PBM spreads and Health Services adjusted operating income. Given PBM scale is a core cash engine, sustained margin erosion here would structurally reduce enterprise cash flow and increase volatility in multi-year earnings.
Regulatory And State-level UncertaintyFragmented state actions and evolving federal rules raise compliance costs and risk altering PBM/pharmacy economics. Structural regulatory shifts can change reimbursement models and access rules, creating persistent margin and operational risks across the retail and PBM businesses over the medium term.
CVS Health News
CVS FAQ
What was CVS Health Corp’s price range in the past 12 months?
CVS Health Corp lowest stock price was €53.35 and its highest was €96.90 in the past 12 months.
What is CVS Health Corp’s market cap?
CVS Health Corp’s market cap is €115.50B.
When is CVS Health Corp’s upcoming earnings report date?
CVS Health Corp’s upcoming earnings report date is Aug 05, 2026 which is in 3 days.
How were CVS Health Corp’s earnings last quarter?
CVS Health Corp released its earnings results on May 06, 2026. The company reported €2.228 earnings per share for the quarter, beating the consensus estimate of €1.893 by €0.335.
Is CVS Health Corp overvalued?
According to Wall Street analysts CVS Health Corp’s price is currently Undervalued.
Does CVS Health Corp pay dividends?
CVS Health Corp pays a Quarterly dividend of €0.579 which represents an annual dividend yield of 2.5%. See more information on CVS Health Corp dividends here
What is CVS Health Corp’s EPS estimate?
CVS Health Corp’s EPS estimate is 1.6.
How many shares outstanding does CVS Health Corp have?
CVS Health Corp has 1,275,927,200 shares outstanding.
What happened to CVS Health Corp’s price movement after its last earnings report?
CVS Health Corp reported an EPS of €2.228 in its last earnings report, beating expectations of €1.893. Following the earnings report the stock price went up 4.751%.
Which hedge fund is a major shareholder of CVS Health Corp?
Currently, no hedge funds are holding shares in DE:CVS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CVS Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€96.38 (1.99% Upside)
€96.38 (1.99% Upside)
Blogger Sentiment
Bullish
DE:CVS Sentiment 84%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth €281.2M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
89.21%
12-Months-Change
Fundamentals
Return on Equity
2.50%
Trailing 12-Months
Asset Growth
-1.02%
Trailing 12-Months
Company Description
CVS Health Corp
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
CVS Company Deck
CVS Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a generally positive tone driven by clear top-line growth, strong cash generation, profit and EPS beats, an upward revision to full-year EPS guidance, meaningful improvement at Aetna (material AOI gain and operational efficiencies), and ongoing technology/AI initiatives (Health100). Offsetting risks include segment-level profit declines (Health Services and PCW), membership impacts from the Individual Exchange exit, continued elevated medical cost trends, PBM rebate pressures and regulatory/state-level uncertainty. On balance, the favorable operating metrics, raised guidance, and credible path to margin recovery outweighed the identifiable challenges.View all DE:CVS earnings summariesCVS Revenue Breakdown
46.57% Health Services
35.05% Health Care Benefits
33.40% Pharmacy & Consumer Wellness
0.12% Corporate/ Other
CVS Stock 12 Month Forecast
Average Price Target
€96.38
▲(1.99% Upside)